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The production of an effective active immunity to viruses which attack the 
central nervous system constitutes a problem which differs in important respects 
from that presented by other virus diseases.  A developing systemic immunity, 
evidenced by the presence of considerable quantities of specific  antibodies in 
the serum, may not prevent an established neural infection from continuing to 
a  fatal  evolution,  while  a  pre-existing  systemic immunity  not  only fails  to 
confer uniform protection to more than small doses of neurally inoculated virus 
but also may fail at times to protect against virus inoculated by extraneural 
routes.  Complete immunity, manifested by uniform resistance to neurotropic 
virus directly introduced into the nervous system, usually has been achieved 
only in those animals which have survived a previous neural infection.  Indeed, 
in some cases such complete immunity may be demonstrated only when the 
challenge dose is placed in that part of the nervous system which actually was 
invaded during the previous infection.  While a complete review of this prob- 
lem is not contemplated, a number of observations in support of these general- 
ities are cited in the following. 
In the field of rabies,  the development  of absolute  immunity to neural  infection 
has  not  been  reported.  Immunization of  mice  by the  intraperitoneal  route with 
virus  adapted to tissue culture does not enable the animals  to resist more than 100 
~t.i..n.  of virulent  virus  inoculated  intracerebrally  (1).  Indeed,  the  measurement 
of the relative resistance  of intraperitoneally  immunized  mice to intracerebral  chal- 
lenge has been made the basis for a recently devised technique for testing the potency 
of individual vaccine preparations  (2).  In dogs, studies of the effectiveness of various 
antirabic  vaccines  (3-5)  have been  made  using  an  extraneural  site,  the  masseter 
muscle, for challenge inocula, since direct  neural inoculation  was considered to con- 
stitute too severe a test.  Even so, an appreciable number of animals in each vaccina- 
tion group developed fatal infections. 
With the viruses of equine encephalomyelitis similar observations have been made. 
Monkeys surviving an extraneural  infection and shown to possess specific antibodies 
* The studies reported  in this paper were carried out in the Rio de Janeiro labora- 
tory of the Servi~o de  Estudos e Pesquizas  sobre a  Febre Amarela  (Yellow Fever 
Research  Service) which  is  maintained  jointly by the Ministry  of Education and 
Health of Brazil and the International Health Division of The Rockefeller Foundation. 
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in their sera did not uniformly resist later cerebral infection (6), while other monkeys 
whose serological immunity had been stimulated by formalized vaccine were found 
in some instances to be still susceptible to virus administered by the nasal route (7). 
Also,  neural  infections in monkeys have been observed  to progress  to their  usual 
fatal  outcome in  spite  of the  development  of significant levels of serum  antibody 
(6,  7).  Studies in mice and rabbits  (8, 9)  have demonstrated particularly well the 
relative nature of the immunity produced by extraneural immunization, since a direct 
correlation was established  between  the  degree of intracerebral  resistance  and  the 
titer of the circulating antibodies.  On the other hand, guinea pigs which had experi- 
enced a non-fatal neural infection following the inoculation of freshly isolated strains 
of Western  equine  encephalomyelitis  virus  were  found completely  immune  to  re- 
inoculation  (10). 
Some  of the  most  interesting  observations  have  been  made  with  poliomyelitis 
virus.  Monkeys with relatively high levels of circulating antibody, acquired either 
by active intravenous  immunization  or by passive  means,  have been found to be 
susceptible  nonetheless  to  intracerebrally  injected  virus  (11).  Even  rrionkeys  re- 
covered from previous attacks  are not wholly resistant  to subsequent  infection by 
the intracerebral or intranasal routes, although the greatest number of second infec- 
tions have been produced with virus of heterologous strains  (12,  13).  An explana- 
tion for these experimentally induced reinfections in monkeys, and also for a number of 
well authenticated instances of second attacks in human beings has been indicated by 
recent studies on recovered monkeys (14).  These studies have shown that resistance 
to reinfection is limited to those regions of the nervous system which actually were 
invaded by virus during the initial infection; parts of the nervous system not previ- 
ously invaded remain susceptible to subsequent infection resulting either from direct 
neural inoculation of virus, or, when that portal had not been employed in initiating 
the prior attack, inoculation by the nasal route.  Finally, observations made with 
the virus of mouse encephalomyelitis, which closely resembles that of poliomyelitis, 
have shown that cerebral infection with an avirulent  strain produces a  much more 
substantial immunity to virulent virus subsequently inoculated intracerebrally than 
does immunization by extraneural routes (15). 
Although the virus of yellow fever  typically does  not produce a  disease of 
the central nervous system in man, it has a  well recognized neurotropic char- 
acter which can be either  augmented (16-18) or greatly reduced (19, 20) under 
proper  conditions.  Because  of this  neurotropism,  it  is  possible  that  certain 
observations made with yellow fever virus may be of significance to workers 
engaged in studying the problem of immunization against othgr viruses which 
primarily  attack  the  central  nervous  system. 
The number of pertinent  observations with yellow fever virus so far reported  is 
small.  The development of serum antibodies has been observed in monkeys which 
subsequently  died  of encephalitis  following extraneural  inoculation of virus  of the 
highly neurotropic  (but no longer viscerotropic) mouse-fixed variant of the French 
strain  (21).  Immune serum, inoculated intraperitoneally in quantities  sufficient to jo~is. P.  Fox  489 
prevent the development of visceral yellow fever, did not prevent the evolution of a 
fatal encephalitis in monkeys infected by the cerebral route with virus of a pantropic 
strain (18).  Even when potent immune serum was injected into the cisterna magna 
some hours prior to the intracerebral  inoculation of French neurotropic virus, only 
a  small  number  of monkeys were protected  (22).  Although active immunization 
with subcutaneously inoculated virus of the relatively avirulent 17D strain has been 
reported to render a high proportion of monkeys resistant to intracerebrally inoculated 
virus of the French neurotropic strain  (20,  23), just  the contrary is reported in the 
present paper.  Finally, recent observations with mice have indicated that animals 
which survive an intracerebrally induced infection with yellow fever virus are very 
resistant  to later inoculation by the same route of large doses of virus of a  highly 
neurotropic strain  (24). 
In the present paper are reported further observations on the resistance  of 
monkeys and mice, immunized by neural and by extraneural  routes,  to intra- 
cerebrally inoculated virus  of the  neurotropic  variant  of  the  French  strain. 
Materials and  Methods 
Yellow Fever Virus.--The strains of yellow fever virus employed were the following: 
lTD.--Now  commonly  used  for  human  vaccination,  this  avirulent  strain  was 
evolved from the pantropic Asibi strain  during a  long series  of passages in  tissue 
culture  (19,  20).  Although producing a  usually fatal encephalitis when inoculated 
intracerebrally  into  mice,  it  has  lost  almost  completely  both  its  neurotropic  and 
viscerotropic virulence for monkeys.  Even when inoculated intracerebrally in these 
animals, it produces an encephalitic process usually so benign that the only clinical 
manifestation is a febrile reaction (20, 23, 25).  Although a number of substrains of 
17D virus with relatively well defined individual characteristics are now recognized 
(24-27) and have been employed in the present work, only one, substrain  17DD low, 
is possessed of special attributes  pertinent  to the present  study.  This substrain  is 
noteworthy for the frequency with which it produces non-fatal infections in mice (24). 
In general, the virus source consisted of vaccines prepared from infected chick embryos 
in the routine manner (28),  although in one instance virus was derived from freshly 
suspended brains of infected mice. 
Asibi.--This pantropic strain, the history of which has been well traced elsewhere 
(19),  is  highly  virulent  for monkeys, producing in  these  animals  a  usually  fatal, 
visceral  disease.  Fresh  or desiccated  serum from inf.ected  monkeys, or Stegomyia 
mosquitoes infected by feeding on monkeys constituted the virus source. 
Jungle Virus.--Several strains of unmodified virus, isolated from human cases of 
jungle  yellow fever,  have  been  used.  Although less  virulent  for rhesus  monkeys 
than the Asibi strain, the jungle strains often produce a fatal disease  of the visceral 
type.  The virus sources employed have been serum from the original human cases 
or from subsequently infected monkeys. 
French  Neurotropic.--This  is  the  highly neurotropic,  mouse-fixed variant  of the 
French strain  (16),  here employed in from the 500th to the 600th serial passage in 
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produces  a  regularly  fatal encephalitis  in both mice and monkeys.  Freshly taken 
brains  from infected  mice,  triturated  and  suspended  in  physiological  saline, have 
served  as  the virus source. 
Eastern Equine Encephalomyelitis Virus.--One  strain of this  virus  has  been  em- 
ployed in verifying the specific nature of the resistance  of animals to intracerebrally 
inoculated  yellow fever  virus.  This  strain  was  obtained  originally  by Dr.  E.  H. 
Lennette from the laboratory of Dr. P. K. Olitsky of The Rockefeller Institute and 
has been maintained  since in serial passage in mice. 
Monkeys.--The  monkeys were all of the common rhesus variety (Macaca mulatta) 
and usually weighed from 2 to 3 kilos. 
Those immunized  by the intracerebral  route had  received  inoculations  into the 
left frontal lobe of 0.5 ml. of a 1:2 or 1 : 10 dilution of routinely  prepared  vaccine con- 
taining  17D  virus. 
Extraneurally immunized  monkeys  fell into three groups.  The largest  of these 
consisted  of animals  utilized  in various  experiments,  which had received  17D virus 
in subcutaneous  doses of varying size.  Another group included monkeys which had 
survived  subcutaneous  inoculation  with virus of one  or another of several  jungle 
strains.  The third group was composed of monkeys which had survived  infection 
with the usually lethal Asibi strain,  induced either by the bite of infected mosquitoes 
or by the subcutaneous  inoculation  of infected monkey serum. 
Mice.--All mice used were adults (over 35 days of age) of the Swiss strain,  bred 
and raised in this laboratory.  Those immunized intracerebrally  represented  animals 
which had survived  infection with 17D virus, usually  of substrain  17DD low.  The 
intraperitoneally  immunized mice were prepared  as described in the text. 
Virus  Titrations.--Virus  titers  were  calculated  by the  50 per cent mortality or 
infectivity end-point  method (29) and were based upon the intracerebral  inoculation 
of 6 or 12 mice per serial fourfold or tenfold dilution of the preparation being titrated. 
As the diluent,  10 per cent normal human or monkey serum in saline was employed. 
Determination of Protective Antibodies.--The  presence of antibodies  against yellow 
fever was determined either, as in the case of a number of monkey sera, by the intra- 
peritoneal  technique employing adult mice (30); or, as in the case of the remaining 
monkey sera,  the mouse sera,  and saline  suspensions  of mouse brains,  by a  more 
sensitive  intraperitoneal  technique  employing  young mice  (26, 31).  Titrations,  in 
either  case, were performed  by testing serial fourfold dilutions  in groups of 6 or 12 
mice. 
Observations in Monkeys 
The following experiments were carried out with the purpose of comparing 
the  resistance  to  intracerebrally  administered  French  neurotropic virus  of 
monkeys immunized by the intracerebral inoculation of 17D virus with that of 
monkeys immunized by the extraneural inoculation of 17D virus or by non- 
fatal systemic infections with the pantropic Asibi and  jungle strains. 
The Resistance of Monkeys to  Intracerebral Doses of French Neurotropic  Virus 
Experiment  /.--This  preliminary  experiment  comprised  a  total  of  12  immune 
monkeys which were inoculated  intracerebrally  with graded doses (from  1.4  X  105 JOHN P. Fox  491 
to 1.4 ×  10  2 M.L.D. for mice) of French neurotropic virus.  The animals, all of which 
had received  their immunizing  infection approximately 2 months previously, were 
divided into three equal groups representing monkeys immunized by the intracerebral 
inoculation of 17D virus  (various  substrains),  by the subcutaneous  inoculation of 
17D virus, and by the subcutaneous inoculation of virus of jungle  origin.  Although 
not included in this experiment, normal monkeys are known to develop invariably 
fatal encephalitis  following intracerebral challenge  doses  much smaller  than those 
here employed.  Immediately before inoculation of the challenge dose, each animal 
was bled to obtain serum for examination in the protection test.  These sera were 
titrated in one or the other of two apparently comparable runs of the adult mouse 
test, using 6 mice per each fourfold dilution of serum. 
The results are shown in Table I.  Of the 4 intracerebrally immunized mon- 
keys,  1  (No. 2)  showed a  possibly significant  febrile reaction, and none de- 
veloped any other signs of encephalitis.  Of the animals immunized subcuta- 
neously with 17D virus, rhesus 5, which had received the largest challenge dose, 
died on the 3rd day with tuberculosis; monkeys 6 and 7, which had received 
the next smaller doses, developed typical, fatal encephalitis; and only No. 8, 
which had received the smallest dose, completely resisted the challenge.  In 
the final group, which had survived infection with unmodified jungle yellow 
fever virus, again only the monkey receiving the smallest challenge dose (No. 
12)  was completely resistant; monkeys 9 and 10 developed typical, fatal en- 
cephalitis, while No. 11 developed a permanent quadriplegia and was sacrificed 
after 30 days. 
Table I  also indicates the serum-antibody titers of these monkeys just prior 
to the  challenge inoculation.  Study of these titers  makes it clear that  the 
superior resistance of the intracerebrally immunized animals  was  not based 
upon a corresponding superiority in the pre-existing level of serological immun- 
ity.  Monkeys 1 and 2, for example, whose serum-antibody titers were 14.5 
and 7.5, resisted inocula of 1.4 X  105 and  1.4 X  104 M.L.D. respectively, where- 
as monkeys9 and 10, whose serum titers (14.5 and 9) were nearly identical with 
those of Nos. 1 and 2,  succumbed to exactly corresponding challenges. 
On the other hand the results suggest that the level of serological immunity 
may have some relation to the resistance to encephalitis of animals immunized 
as the result of extraneural infection.  Comparing only those animals which 
received equivalent challenge inocula, i.e., No. 6 with No.  10 and No. 7 with 
No. 11, it is seen that the encephalitis in those with the higher antibody titers 
was of later onset and much longer duration. 
Experiment  2.--In  a  second,  larger  experiment  14  intracerebrally  immunized 
monkeys were challenged with graded intracerebral doses of French neurotropic virus 
ranging from 1.2  ×  l0 s to 1.2  X  104 ~.L.D. for mice.  These animals  had received 
immunizing  inocula  of 17D virus (substrain  17D-NY  104) 5 weeks  (11 animals), 9 
months (monkey 18), and 17 months (monkeys 21 and 24) previously.  In addition, 
4 monkeys, immunized 3 months previously as the result of non-fatal systemic infec- 492  IMMUNITY  TO  YELLOW  FEVER  ENCEPHALITIS 
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tions with Asibi virus, were given challenge  doses of from 1.2  ×  106 to 1.2  ×  103 
~.L.9.;  and 10 monkeys, inoculated subcutaneously with virus of substrain 17D-N¥ 
104 5 weeks previously, were challenged  with inocula containing from 1.2  X  106 to 
1.2  X  102 ~r.L.D. 
As in Experiment 1, pre-chaUenge sera from all of the animals  were titrated for 
protective antibody.  In this case, however, the protection test technique employing 
young mice was used,  12 being inoculated for each fourfold dilution of serum.  It 
must be noted that,  because  the different technique resulted in  a  test of greater 
sensitivity, the titers presented for Experiment 2 are not to be compared with those 
presented for Experiment 1. 
The results are presented in Table II.  As in the previous experiment, all 
of the animals previously inoculated with 17D virus by the intracerebral route 
resisted the test inocula, while most of those which had been inoculated with 
the same virus by the subcutaneous route succumbed.  On the other hand, the 
4 animals immunized with the pantropic Asibi virus all resisted the challenge 
doses, in contrast to the results obtained in the preceding experiment with the 
animals immunized with pantropic virus of jungle origin. 
Although, as has been reported elsewhere (25), the monkeys immunized by 
the inoculation of 17D virus intracerebrally manifested a higher average level 
of antibody in the preinoculation sera than did those immunized with the same 
virus by the subcutaneous route, it is again evident that the uniform resistance 
of the former group cannot be explained on a  serological basis.  At least 6 
animals in the intracerebrally immunized group yielded serum-antibody titers 
no higher than those observed in some of the subcutaneously immunized ani- 
mals which succumbed to the challenge dose.  It is possible, however, that the 
relatively high levels of serum antibody in monkeys 37 and 38, immunized by 
the subcutaneous inoculation of 17D virus, and in monkeys 27 to 30, the Asibi 
immunes, may have played some r61e in their resistance. 
Although it appears from the two preceding experiments that complete re- 
sistance to cerebral infection with neurotropic yellow fever virus results from 
a prior cerebral infection with 17D virus, it should be noted that the challenge 
inocula in both experiments were placed in the same site, the left frontal area, 
as the immunizing inocula.  This is of significance since it has been shown that 
absolute resistance to second infections with the virus of poliomyelitis is ob- 
served only when the challenge inoculum is placed in that part of the central 
nervous system actually affected during  the  initial  infection  (14).  A  third 
experiment, therefore, was undertaken to study the resistance of intracerebrally 
immunized monkeys to neurotropic virus placed in a different part of the ner- 
vous system. 
Experiment 3.--8  monkeys, which  had  been inoculated with  17D  virus by the 
intracerebral route 9 months before, were given challenge inocula containing 3.3  X 108 
M.L.D. of French neurotropic virus.  In 4 animals  the challenge dose, like the pre- 494  IMMUNITY  TO  Y~LLOW  FEVER  ENCEPHALITIS 
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ceding immunizing  inoculum,  was placed in the left frontal lobe, while in the other 
4 a  site in the right frontal lobe was employed.  All of the animals  were carefully 
observed for a period of 30 days. 
One monkey in each group developed fever (a rectal temperature over 40°C.) on 
the 4th day but in both cases this promptly subsided.  No other indication of an 
encephalitic  reaction was  observed. 
From this experiment it can be concluded that, in monkeys inoculated with 
17D  virus intracerebrally, the  subsequent  resistance of  the  central  nervous 
system to infection with neurotropic virus is not limited to the area receiving 
the immunizing inoculum. 
Resistance of Monkeys to the Virus of Eastern Equine Encephalomyelitis 
That resistance to cerebral infection with a highly neurotropic virus may have 
a non-specific basis has been recently pointed out (9).  To test this possibility 
in the present case the virus of Eastern equine encephalomyelitis was employed. 
Intracerebral challenge inocula of this virus containing from 1.7  X  10  6 to 1.7 
X  10  4 ~.L.D. for mice were administered to  3 of the monkeys whose  survival 
of a  maximum challenge dose of neurotropic yellow fever virus had been de- 
monstrated 6 months previously in Experiment 3. 
All three monkeys died within 3 to 4 days with typical signs of encephalitis. 
This result indicated the probably specific nature of their previously demon- 
strated  resistance  to  French  neurotropic virus. 
Observations in Mice 
The observations just reported have led to the conclusion that,  in marked 
contrast to the behavior of monkeys immune to yellow fever as the result of 
systemic infections, monkeys whose immunity has resulted from actual cere- 
bral infection manifest an absolute resistance to direct challenge of the nervous 
system  with  virus  of  a  highly  neurotropic  strain.  Furthermore,  this  re- 
sistance is probably to be explained on the basis of a  mechanism of localized 
nature since it apparently is independent of the degree of pre-existing systemic 
immunity as measured in terms of serum-antibody titers. 
It has recently been shown that mice which survive cerebral infection with 
yellow fever virus of several strains also are highly resistant to maximal intra- 
cerebral doses  of virus of  the virulent French  neurotropic  strain  (24).  It 
remained to compare the resistance of such mice with that of mice immunized 
by extraneural routes; and also to extend the studies in this inexpensive animal 
in an effort to demonstrate the mechanism of the localized resistance which 
intracerebratly immunized animals apparently possess. 
Resistance to Neurotropic Yellow Fever Virus 
A study~was first made of the comparative resistance to French neurotr0plc 
virus of mice surviving a  previous cerebral infection, and of mice immunized JOnN  p. Fox  497 
by extraneural inoculation, for which the intraperitoneal route was chosen for 
its obvious convenience. 
ExperimentaL--Since  it  was  proposed  to  collect  the  intracerebrally  immunized 
mice from survivors  of infections with 17D virus,  this  strain  (substrain  17DD low) 
was  also  employed  for  purposes  of  intraperitoneal  immunization.  Preliminary 
experiments  revealed  that intraperitoneal  doses containing  at least  4  X  104 M.L.D. 
of virus were necessary  to provoke regularly  a  serologically detectable  immune  re- 
sponse; and that reinoculation with a large virus dose at about the peak of the primary 
immune  response  (21  days later)  resulted  in a  greatly augmented  serum-antibody 
level. 
Following this basic technique,  two large lots of intraperitoneally  hyperimmunized 
mice were prepared,  the first  and second inocula in both cases containing between 
l0  s and  106 MJ..D. of virus.  These  immunizing inocula consisted of  suspensions of 
TABLE III 
The  Resistance of Intraperitoneally  and  of Intracerebrally Immunized  Mice to Intracerebral 
Challenge Doses of French Neurotropic Virus 
Method of immunization 
Intraperitoneal: 
One inoculation  ........... 
Two inoculations  .......... 
Cerebral infection  ........... 
Normal controls  ............. 
Mortality ratios  of mice challenged  with doses  of (M.L.D.) 
5 X  10  s 
10/20 
10/57 
1/82 
42•42 
5 X  105 
9/11 
9/24 
42/42 
5XlO 4 
4/11 
7•24 
41/41 
5 X  10~ 
4/10 
6/33 
41/41 
5 X  lOZ 
5/11 
42/42 
5 X  10~ 
13/22 
0/17 
41/41 
All doses 
45/85 
32/155 
1/82 
249/249 
infected  mouse brain rather than the usual  chick embryo preparations  to avoid the 
possible  occurrence  of  anaphylactic reactions.  At  intervals  during  the  course  of 
the immunization,  mice from these lots  together with animals  which had survived 
cerebral infection were subjected  to intracerebral  challenge with French neurotropic 
virus, using as controls normal mice of the same age as  the intraperitoneal  immune 
mice.  The results  have been  expressed  as  the ratio of the number of mice dying 
as  the result of the challenge inocula to the number tested (mortality ratio). 
Results.--The observations have been summarized in Table III.  It is evi- 
dent that some degree of resistance to cerebral infection was conferred by intra- 
peritoneal  immunization,  since many mice so immunized survived  the  chal- 
lenge inocula whereas all of the normal  controls  succumbed.  Furthermore, 
this  resistance  was clearly augmented by the  hyperimmunizing inoculation. 
Of the 85 mice tested after a  single immunizing infection, 45  (or 53 per cent) 
developed a fatal encephalitis whereas only 32 (or 21 per cent) of the 155 hyper- 
immunized  mice  succumbed.  This  resistance,  however,  was  complete  only 
in the groups of hyperimmunized mice which received the smallest challenge 
dose (5  X  101 M.L.D.).  Otherwise,  little  relation is  evident between the size 498  IMMUNITY TO YELLOW  FEVER  ENCEPHALITIS 
of the challenge inoculum and the proportion of mice succumbing.  In sharp 
contrast to this picture of irregular and incomplete resistance are the results 
observed for the mice whose immunity had resulted from previous non-fatal 
cerebral infection.  Of 82 such mice tested, only 1 failed to survive. 
Resistance to Eastern Equine Encephalomyelitis  Virus 
To parallel the similar study in monkeys, an attempt was made to verify 
the specific nature of the resistance of yellow fever-immune mice to cerebral 
infection with a  highly neurotropic yellow fever virus. 
ExperimentaL--In  graded  doses  containing from approximately 5  to  5  X  103 
M.L.D. as determined by titration in normal mice (using 12 mice per decimal dilution), 
Eastern equine encephalomyelitis  virus was administered intracerebrally to 81 mice 
which had survived a challenge inoculum of French neurotropic virus given from 12 
to 21 days previously.  These mice represented survivors from a miscellaneous group 
of experiments;  they included not only animals which had survived previous cerebral 
infection with yellow fever virus of several strains but also nearly 50 mice which had 
received, while from 3 to 7 days of age, subcutaneous or intraperitoneai inoculations 
of Asibi virus. 
Results.--Of 45 mice receiving 5 X  102 or 108 M.L.D. of equine virus, all died; 
of 24 mice  inoculated  with 5  X  101 M.L.D., 16 died;  and of 12 mice given 5 
M.L.D., 2 died.  Thus, it would appear  that these yellow fever-immune mice 
were capable of resisting about 10 M.L.D. of equine virus.  It was  noted also 
that the average time of death of these mice was significantly longer than that 
of normal control mice receiving equivalent virus doses.  Deaths among the 
test mice occurred on from the 2nd to the 6th day, with an average of 3.3 days, 
whereas deaths among the control mice occurred 
days with an average of 2.7  days. 
These observations indicate that mice known 
doses of neurotropic yellow fever virus may be 
on from the 2nd to the 4th 
to resist large  intracerebral 
capable of a  slight  though 
definite resistance to a  heterologous neurotropic virus of considerable virul- 
ence.  Perhaps this  non-specific  resistance  is to be explained by a  residual 
process of inflammation resulting from the rather recent challenge inocula to 
which the mice had been subjected.  Whatever its explanation, however, the 
degree of non-speclfic resistance demonstrated is very small as compared to 
that  of the  previously demonstrated  resistance  to  neurotropic yellow fever 
virus. 
Protective Antibodies in the Sara and Brains of Intracarebrally and 
Intraperitoneally Immunized Mice 
In an attempt to explain the basis for the superior and largely specific re- 
sistance of the nervous system of animals surviving a previous neural infection, 3om~  1,.  Fox  499 
studies were made of the comparative protective capacity against yellow fever 
virus of serum pools and brain  suspensions from neurally and extraneurally 
immunized mice. 
ExperimentaL--On the same occasions that the intracerebrally and intraperitoneally 
immunized  mice were tested for their resistance to intracerebrally inoculated French 
neurotropic virus, identically immunized mice, in groups  of from 4 to 8, were ex- 
sanguinated from the heart to obtain serum for pools.  The brains of these mice 
were also collected, pooled to correspond with the respective sera, and then triturated 
and suspended  in physiological saline in a  10 per cent concentration.  These serum 
and brain suspension pools were titrated for their protective action; 12 young mice 
were used per fourfold dilution of each pool.  In all cases, corresponding  serum and 
brain suspension  pools were examined  in the same protection test runs. 
Results.--The  results of these  examinations are recorded in Table IV. 
Turning first to the sera, the important fact is that in general the titers of the 
pools from the intraperitoneally hyperimmunized mice, averaging 595, greatly 
exceeded those obtained for the pools from mice immunized intracerebrally, 
which averaged only 114.  Thus, while the high levels of serum antibody ob- 
served in the hyperimmunized mice may have been responsible for their being 
relatively more resistant than mice immunized with but a single intraperitoneal 
inoculation, no similar basis can be advanced for the nearly complete resist- 
ance of the intracerebrally immunized animals. 
Examination of the results obtained for the brain suspension pools reveals 
that, although the serum-antibody levels of the hyperimmune mice were much 
higher than those of the mice surviving cerebral infection, a significant though 
low degree of protective activity was demonstrated only in the brain suspen- 
sions from the latter group.  On  the basis  of the average figures presented 
(titers recorded as less than 2 were assigned the arbitrary value of 1), the titers 
of brain suspensions from the cerebral immunes (6.4) were" 5.3  times greater 
than those of the hyperimmune mice (1.2).  This observation strongly suggests 
that the local mechanism responsible for the uniform resistance of the neurally 
immunized mice (and presumably monkeys as well) is based at least in part 
upon  a  concentration  of  specific protective antibodies  in  the  neural  tissue 
fluid. 
The Development of Immunity in Intracerebrally Inoculated  Mice 
Since mice which survive an intracerebral infection are the exception rather 
than the rule, it is obviously impossible to study  the development of the im- 
mune process contributing to their survival.  It is possible and of some inter- 
est, however, to study the development of immunity in mice inoculated intra- 
cerebrally with 17D virus of a substrain (17DD low) which is known to produce 
relatively frequent non-fatal infections. 500  IMMUNITY  TO YELLOW  ]~EVER ENCEPHALITIS 
ExperimentaL--Two  groups  of  60  normal  adult  mice each were inoculated  with 
virus doses (determined in a coincidental titration)  of 512 and 32 ~r.L.D. respectively, 
TABLE IV 
Protective Antibody  Content of Pooled Sera and Brain Suspensions from Intracerebrally 
and lntraperitoneally Immunized Mice 
Immunization (17D virus) by: 
One  inoculation  intraperi- 
toneally 
Two inoculations intraperi- 
toneally 
Prior cerebral infection 
No. of mice 
6 
6. 
12 
36 
74 
Antibody  titer of pools 
Sera 
22 
64 
43* 
250 
930 
950 
314 
325 
800 
Brain suspensions 
m 
<2 
<2 
<2 
<2 
1.3 
3.0 
1.2 
0 
595*  1.2" 
256 
158 
74 
39 
47 
182 
132 
81 
136 
98 
38 
126 
114" 
5.1 
6.1 
10.0 
8.0 
5.3 
3.5 
5.0 
5.7 
6.2 
15.2 
4.0 
4.0 
5.7 
6.4* 
<  =  less than the lowest dilution tested. 
* Average fiters. 
At daily intervals thereafter, sera and brains, formed into corresponding pools, were 
obtained  from  representative  mice  sacrificed  from  each  group  by  exsanguination. 
The  brains  were  immediately triturated,  suspended  in  physiological saline  in  a  20 
per cent concentration,  and titrated for their content of active virus; 6 normal ,:.:;ce jom~  I,.  fox  501 
were  inoculated  per  decimal  dilution.  Subsequently,  when  their  infectivity had 
been lost, residual portions of the brain suspension pools and the corresponding serum 
pools were examined for their protective activity in the young mouse protection test, 
the undiluted specimens being tested in 6 mice each.  The results of these examina- 
tions have been expressed as the ratio of the number of mice protected to the number 
tested (protection ratio or PR). 
TABLE V 
The Development of Infection and Immune Response in Mice Inoculated Intracerebrally 
with 17D Virus 
Day 
post-inocu- 
lation 
9 
10 
11 
12 
No. of mice 
sacrificed* 
3w 
3w 
3w 
3w 
3w 
5w 
4w 
5s 
5s 
3s 
2s 
Alldead 
512 ~.LD. inoculated 
PR of  Brain suspension  pools  No. of 
serum  mice sac- 
pools  Pn  Virus titer~ i  rificed* 
0/6  0/6  >I 
0/6  2/6  >1 
0/6  2/6  >100 
1/6  1/6  10,000 
0/6  1/6  100,000 
0/6  2/6  320,000 
6/6  1/6  70,000 
6/6  1/6  200,000 
6/6  1/6  200,000 
6/6  1/6  25,0~0 
x  1/6  250,000 
32~.~.D.  inoculated 
PR of 
serum 
pools 
3w  0/6 
3w  1/6 
3w  0/6 
3w  0/6 
3w  0/6 
3w  5/6 
3w 
5w 
3s 
3/6 
5/6 
5/6 
3s  6/6 
7s  5/6 
3s  6/6 
5s  5/6 
Brain suspension pools 
PR  Virus tlter$ 
0/6  -  0 
2/6  >1 
0/6  > 100 
1/6  3,200 
3/6  10,000 
2/6  40,000 
4/6  8o,oo0 
2/6  70,000 
0/6  400,000 
1/6  600,000 
0/6  25,000 
1/6  7,000 
0/6  400,000 
>  =  end-point not reached. 
x =  serum specimen not sufficient for testing. 
* w =  mice sacrificed appeared well, s =  mice already sick. 
:~ Titers given are of 20 per cent suspensions.  For full brain titers, multiply by five. 
On the 7th and 8th days separate pools of brains and sera were made for mice still 
apparently normal and for mice already sick.  The observations were terminated on 
the 10th and 12th days by the death from encephalitis of the remaining mice. 
Results.--Table  V  contains  the  results.  Definite protective capacity was 
demonstrated in the sera collected on and after the 6th or 7th days.  In spite 
of this the active virus content of the brains continued high or even increased, 
and  the disease progressed to its usual  fatal termination in all the mice not 
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The observations as to the protective capacity of the brain suspensions are 
inconclusive since Pl~'S of 2/6 were obtained for specimens collected as early as 
the 2nd day after inoculation yet were not followed by a series of more certainly 
positive results.  These inconclusive results, for the most part, probably repre- 
sent a reduction in the effectiveness of the standard test dose of virus due to 
its  partial  inactivation  when  diluted  in  the  saline-brain  suspension.  It  is 
possible, however, that the PR'S of from 2/6 to 4/6 which were obtained for 
the 5, 6, 7, and 8 day specimens from mice inoculated with 32  ~.L.D. indicate 
specific  protective effect.  If this be  true,  the negative results obtained for 
specimens collected subsequently, and the failure to detect a similar indication 
in the 512 M.L.D. series may have been due to a masking of antibody in the 
cerebral tissue fluid by its full combination with the 17D virus present origin- 
ally in the brains in relatively high concentration. 
Taken in their entirety, the results of this experiment make little contribution 
to the elucidation of the resistance of intracerebrally immunized mice.  They 
do, however, provide one more example of the failure of a developing systemic 
immunity to modify the course of an already established neural infection. 
DISCUSSION 
The evidence presented suggests that the problem of immunizing the nervous 
system against a neurotropic strain of yellow fever virus--a somewhat academic 
problem, to be sure--is not dissimilar to that with respect to primarily neuro- 
tropic viruses.  Neural infections proceed in their fatal evolution in the face of 
a developing systemic immunity; pre-existing systemic immunity confers only 
irregular protection against direct neural infection with virulent virus; and only 
following prior neural infection does'complete immunity of the central nervous 
system become established. 
The  usual failure,  observed  in  the present  experiments,  of  monkeys im- 
munized by the extraneural inoculation of 17D virus to resist neural infection 
with French neurotropic virus is at some variance with the experience of other 
workers (20,  23)  who reported the occurrence of but 1 fatal and 2 non-fatal 
cases of encephalitis among eleven animals subjected to intracerebral challenge. 
The amount of virus contained in the challenge inocula, however, was not in- 
dicated in these reports and may have been relatively small. 
It has been demonstrated recently that in animals immunized by extraneural 
routes  resistance  to  neural infection with the viruses of equine encephalo- 
myelitis is directly related to the presence of specific antibodies in the nervous 
system in demonstrable concentrations, and that this in turn is contingent upon 
a titer of serum antibody of at least 300 (9).  In the present case, some parallel- 
ism was evident between the resistance of extraneurally immunized animals 
and their level of serum antibody.  However, in experiments with mice, anti- 
body could not be demonstrated regularly in the brain even in cases in which 
the serum-antibody titer greatly exceeded 300. JOHN P.  FOX  503 
In  contrast  to  the  relative nature  of  the  resistance  of extraneurally im- 
munized animals, that manifested by animals which have undergone a  prior 
neural infection is so absolute as to suggest that they are completely refractory. 
The facts that the resistance of cerebrally immunized animals is long lasting (at 
least 17 months in the case of monkeys and 114 days in the case of mice) and is 
not equally valid against the virus of Eastern equine encephalomyelitis make it 
unlikely that this resistance is based upon a non-specific mechanism analogous 
to the refractory state of damaged anterior horn cells to infection with polio- 
myelitis virus  (32),  or to the resistance of the regenerating nasal mucosa of 
ferrets to influenza virus (33).  Finally, the  resistance observed has no evi- 
dent relation to the degree of the coincidentally existing systemic immunity. 
The best explanation, therefore, for the superior resistance to cerebral in- 
fection with yellow fever virus manifested by intracerebmlly immunized ani- 
mals would seem to be that it is based upon a specific local mechanism.  The 
persistance of yellow fever virus has recently been demonstrated in the brains 
of monkeys which remained apparently normal following intracerebral inocu- 
lation with 17D virus and which died with tuberculosis 2, 3, or 5 months after 
inoculation (34).  Although no virus could be found in the brains of equiva- 
lently inoculated but non-tuberculous monkeys which were deliberately sacri- 
ficed, and although numerous attempts to demonstrate virus in the brains of 
mice surviving 17D virus infection were also unsuccessful (24), the above obser- 
vation suggests that the resistance might be based on a blocking effect, similar 
to that observed by Hoskins (35),  produced by small amounts of living 17D 
virus persisting indefinitely in the brain.  On the other hand, the data con- 
tained in the present paper suggest that the local mechanism may have a truly 
immunological basis, since brains from cerebrally immunized mice were found 
to contain much more protective antibody than brains from intraperitoneally 
hyperimmunized mice, even though the latter manifested much higher titers 
of antibody in their sera. 
The concept of the production of a local tissue immunity is an old one and 
has been adequately discussed elsewhere (36-42).  In the past, however, the 
concept has been limited chiefly to immunity against bacterial infections and 
to  tissues  other  than  those  of  the  nervous  system, although workers  with 
poliomyelitis virus, at least, have differentiated tissue resistance from systemic 
humoral immunity (11,  13,  14,  43,  44).  Considerable discussion as  to  the 
mechanism of local tissue immunity has been entered into, particularly as to 
the relative importance of cellular  versus  humoral factors.  In at least two 
instances, however, the production of antibodies in the local site of immuniza- 
tion has been demonstrated (41, 42). 
In the present instance the data do not permit any conclusions as to the 
source of the antibodies demonstrated in the brain.  Under normal conditions, 
apparently because of the effective barrier action of cerebral capillaries to the 
globulin molecules in the serum, the tissue fluid of brain and the cerebrospinal 504  IMMUNITY  TO  YELLOW  FEVER  ENCEPHALITIS 
fluid  contain only very small  amounts of antibody in comparison  with the 
content of the circulating blood  and of tissue  fluid from other tissues  (45). 
However,  the encephalitic process from which all of these neurally immunized 
animals had recovered  is in essence a  type of inflammatory reaction which 
might be expected  to have altered greatly the normal vascular permeability. 
Since antibodies are known to accumulate in areas of active inflammation (46), 
it is possible that the antibodies found in the mouse brains may have accumu- 
lated while the encephalitic process was still active.  The re-establishment  of 
the normal barriers upon recovery might then have served to prevent the dis- 
persion  of this unusual accumulation of antibodies at a  rate faster than the 
slow rate of antibody accumulation in the brain under normal conditions. 
Finally, the attainment in monkeys of complete resistance  to neural infec- 
tion with virulent yellow fever virus by the prior neural inoculation of a virus 
strain relatively avirulent for monkeys suggests a line along which investiga- 
tions with primarily neurotropic viruses might be directed.  Although direct 
immunization of the nervous system would appear to be a drastic procedure, 
the development of relatively non-neurotropic  strains of such viruses as those 
of rabies  and poliomyelitis  in particular might justify its application under 
certain conditions.  Such direct immunization might, for instance, be reason- 
ably applicable  and yield more certain results than present methods in the 
face of known exposure to rabies. 
SUMMARY  AND  CONCLUSIONS 
Monkeys and mice surviving  cerebral  infection with yellow  fever virus of 
relatively avirulent strains have been  found to resist  maximal intracerebral 
doses of yellow fever virus of a highly neurotropic strain.  Such animals, how- 
ever,  do not resist  more than very small  doses of intracerebrally inoculated 
virus of Eastern equine  encephalomyelitis. 
Animals immunized by extraneural routes, on the other hand, are not uni- 
formly resistant to neural infection with neurotropic yellow fever virus.  Mon- 
keys which have undergone systemic infection with virus of the avirulent 17D 
strain or of several jungle strains resist only small intracerebral doses of neuro- 
tropic virus; while mice, even when possessed of very high  serum-antibody 
levels as the result of  intraperitoneal hyperimmunization, manifest only an 
irregular resistance to intracerebral challenge inocula. 
The difference in the resistance  of neurally and extraneurally immunized 
animals is not related to similar differences in the levels of protective antibody 
in the sera.  Indeed, the average of the serum-antibody titers of the hyper- 
immune mice is several times that of the intracerebral immunes. 
A possibly significant relation does exist, however, between the resistance of 
mice to neural infection and the content of protective antibody in the brain. 
The protective activity of suspensions of brains from mice surviving cerebral jom~ P.  ~'ox  505 
infection was found to  be  several times that of brain suspensions from the 
hyperimmunized animals. 
It is concluded that the superior resistance to neural infection of animals 
whose immunity results from a  previous non-fatal infection of the nervous 
system is effected by a specific local mechanism which is based at least in part 
upon an increased concentration of antibody in the cerebral tissue. 
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